Inventiva (IVA) Short-Term Debt issuances (2024)
Inventiva's (IVA) quarterly Short-Term Debt issuances came in at $3205.8 in Q4 2024.
Inventiva (IVA) Short-Term Debt issuances (2024) Analysis & Trends
Inventiva's Short-Term Debt issuances history runs 1 years deep, the most recent figure standing at $3205.8 for Q4 2024.
- On a quarterly basis, Short-Term Debt issuances changed N/A year-over-year to $3205.8 in Q4 2024; TTM through Dec 2024 was $3205.8, a N/A change from a year earlier, with the FY2024 full-year figure at $3205.8, changed N/A from the prior year.
- Short-Term Debt issuances steadied at $3205.8 in Q4 2024 per IVA's latest filing.
- Across five years, Short-Term Debt issuances topped out at $3205.8 in Q4 2024 and bottomed at $3205.8 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Short-Term Debt issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 58.20 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 3,205.79 |
| Dec 31, 2024 | 3,205.79 |